Inventor
BARAN JOHN S
77 patents
⚠️ This page may combine multiple inventors who share the name “BARAN JOHN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
48 patentsUS4499289AFeb 12, 1985
Octahydronapthalenes
SEARLE & CO208 citations99
US5089471AFeb 18, 1992
Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents
SEARLE & CO115 citations96
US4902706AFeb 20, 1990
Aminoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents
SEARLE & CO51 citations96
US4514332AApr 30, 1985
Tetrapeptide adamantyl amides
SEARLE & CO31 citations91
US5424319AJun 13, 1995
Piperidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO9 citations82
US5227401AJul 13, 1993
Ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO16 citations82
US5223535AJun 29, 1993
Propargyl glycine amino propargyl diol compounds for treatment of hypertension
SEARLE & CO12 citations82
US4657931AApr 14, 1987
N-(acyldipeptidyl)-aminoglycols
SEARLE & CO20 citations82
US3972907AAug 3, 1976
Anti-hyperlipidemic fatty acids and esters
SEARLE & CO18 citations82
US4645858AFeb 24, 1987
Pentanedioic acid derivatives
SEARLE & CO18 citations81
US4622338ANov 11, 1986
Substituted glutaric acid lactones in the treatment of hyperlipidemia
SEARLE & CO18 citations80
US6342624B1Jan 29, 2002
Use of propargyl glycine amino propargyl diol compounds for inhibiting plasma renin activity
SEARLE & CO4 citations74
US5484812AJan 16, 1996
Propargyl glycine amino use of propargyl diol compounds for treatment of ophthalmic disorders
SEARLE & CO5 citations74
US5484811AJan 16, 1996
Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders
SEARLE & CO6 citations74
US5416111AMay 16, 1995
Cyano-containing n-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO3 citations74
US5416119AMay 16, 1995
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
SEARLE & CO5 citations74
US5416095AMay 16, 1995
Tetrahydro-quinolinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO3 citations74
US5416104AMay 16, 1995
Oxazolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO2 citations74
US5414012AMay 9, 1995
Indalyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO2 citations74
US5411962AMay 2, 1995
Benzomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO4 citations74
US5246969ASep 21, 1993
Di-propargyl-containing aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertension
SEARLE & CO6 citations74
US5180744AJan 19, 1993
Aralkyl-N-terminal amino hydroxy
SEARLE & CO9 citations74
US4931429AJun 5, 1990
α-aminoacyl β-aminoacyl aminodiols as anti-hypertensive agents
SEARLE & CO13 citations74
US4900746AFeb 13, 1990
Ethereal N-terminal aminodiol amino acid derivatives as anti-hypertensive agents
SEARLE & CO9 citations74
US4900745AFeb 13, 1990
Poly(aminoalkyl)aminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
SEARLE & CO12 citations74
US5137904AAug 11, 1992
Thiohydantoin inhibitors of collagen-induced and ADP-induced platelet aggregation
SEARLE & CO7 citations66
US6174923B1Jan 16, 2001
Use of ethynyl alanine amino diol compounds for treatment of renin-mediated disorders
SEARLE & CO2 citations63
US5968984AOct 19, 1999
Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5942548AAug 24, 1999
Use of ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO5 citations63
US5756549AMay 26, 1998
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
SEARLE & CO2 citations63
US5488066AJan 30, 1996
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
SEARLE & CO2 citations63
US5432201AJul 11, 1995
Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension
SEARLE & CO3 citations63
US5428054AJun 27, 1995
Pyurrolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5428064AJun 27, 1995
N-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiolsas anti-hypertensive agents
SEARLE & CO1 citations63
US5420127AMay 30, 1995
Morpholino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5418249AMay 23, 1995
Thiazolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5416085AMay 16, 1995
3-oxa-8-azabicyclo[3.2.1]oct-8-yl terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5416092AMay 16, 1995
3-azabicyclo[3.2.1]-oct-8-yl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5416083AMay 16, 1995
Benzodiazepinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5411958AMay 2, 1995
Benzothiomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5411957AMay 2, 1995
3-azabicyclo[3.2.1]-nonanyl-terminated non-piptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
SEARLE & CO1 citations63
US5314920AMay 24, 1994
Ethynyl-alanine aryl/alkylsulfonyl-terminated amino-diol compounds for treatment of hypertension
SEARLE & CO3 citations63
US5312838AMay 17, 1994
β-alanineamide aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
SEARLE & CO5 citations63
US5283250AFeb 1, 1994
Quinolinyl/quinolinylalkyl-N-terminal amino hydroxy
SEARLE & CO2 citations63
US5246959ASep 21, 1993
Poly(aminoalkyl)aminocarbonyl aminoacyl aminodiol amino acid derivatives as anti-hypertensive agents
SEARLE & CO4 citations63
US5229369AJul 20, 1993
Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
SEARLE & CO3 citations63
US5223514AJun 29, 1993
Quinolinyl/quinolinylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
SEARLE & CO2 citations63
US5223532AJun 29, 1993
Chromonyl/chromonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino derivatives
SEARLE & CO2 citations63
PHARMACIA CORP
2 patentsUS6667414B2Dec 23, 2003
Use of propargyl glycine amino propargyl diol compounds for treatment of congestive heart failure
PHARMACIA CORP1 citations63
US6515025B2Feb 4, 2003
Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I
PHARMACIA CORP2 citations63
Showing the top 50 of 77 patents by PatentIndex Score.